Your browser doesn't support javascript.
loading
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years.
Oh, Jiwon; Achiron, Anat; Celius, Elisabeth G; Chambers, Christina; Derwenskus, Joy; Devonshire, Virginia; Hellwig, Kerstin; Hutton, George J; McCombe, Pamela; Moore, Marie; Rog, David; Schneider, Jean-Raphael; Simm, Renata Faria; Sousa, Livia; Vincent, Stephen G; Chung, Luke; Daizadeh, Nadia; Mitchell, Colin; Compston, D Alastair S.
Afiliação
  • Oh J; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: ohjiw@smh.ca.
  • Achiron A; The Chaim Sheba Medical Center, Tel Hashomer, Israel; Tel Aviv University, Tel Aviv, Israel. Electronic address: anat.achiron@sheba.health.gov.il.
  • Celius EG; Oslo University Hospital Ullevål and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: uxelgu@ous-hf.no.
  • Chambers C; University of California San Diego, La Jolla, CA, United States. Electronic address: chchambers@ucsd.edu.
  • Derwenskus J; Murfreesboro Medical Clinic and SurgiCenter, Murfreesboro, TN, United States.
  • Devonshire V; University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: jderwenskus@mmclinic.com.
  • Hellwig K; St. Josef Hospital, Ruhr University Bochum, Bochum, Germany. Electronic address: k.hellwig@klinikum-bochum.de.
  • Hutton GJ; Baylor College of Medicine, Houston, TX, United States. Electronic address: ghutton@bcm.edu.
  • McCombe P; The University of Queensland, Brisbane, Australia. Electronic address: pamela.mccombe@uq.edu.au.
  • Moore M; Carolinas Health MS Center, Charlotte, NC, United States. Electronic address: marie.m.moore@carolinashealthcare.org.
  • Rog D; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, United Kingdom. Electronic address: david.rog@srft.nhs.uk.
  • Schneider JR; MS and Neuromuscular Center of Excellence, Clearwater, FL, United States. Electronic address: jeanraphaelschneider@gmail.com.
  • Simm RF; Universidade de São Paulo, São Paulo, Brazil. Electronic address: rfsimm@gmail.com.
  • Sousa L; Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. Electronic address: liviadiogosousa@gmail.com.
  • Vincent SG; Idaho Falls MS Center, Idaho Falls, ID, United States. Electronic address: svincentmd@gmail.com.
  • Chung L; Sanofi, Cambridge, MA, United States. Electronic address: luke.chung@sanofi.com.
  • Daizadeh N; Sanofi, Cambridge, MA, United States. Electronic address: nadia.daizadeh@sanofi.com.
  • Mitchell C; Sanofi, Cambridge, MA, United States. Electronic address: colin.mitchell@sanofi.com.
  • Compston DAS; University of Cambridge, Cambridge, United Kingdom. Electronic address: alastair.compston@medschl.cam.ac.uk.
Mult Scler Relat Disord ; 43: 102146, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32498033
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resultado da Gravidez / Esclerose Múltipla Recidivante-Remitente / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resultado da Gravidez / Esclerose Múltipla Recidivante-Remitente / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article